Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2024-03-29 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2023 年度内部控制自我评价报告' which translates to '2023 Annual Internal Control Self-Evaluation Report'. It is a detailed report on the company's internal control system, its effectiveness, and compliance with relevant laws and regulations as of December 31, 2023. The content includes evaluation conclusions, control activities, risk assessments, and internal audit findings. It is not a financial statement report like an Annual Report (10-K) or Interim Report (IR), nor is it an announcement or certification. The document is a standalone internal control self-evaluation report, which fits the definition of an Audit Report / Information (AR) as it relates to internal control evaluation and audit-related information. The document length (7181 characters) and detailed content confirm it is the report itself, not just an announcement. Therefore, the appropriate classification is AR with high confidence. FY 2023
2024-03-29 Chinese
年度募集资金使用情况专项说明
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the annual status of the company's raised funds, including amounts raised, usage, management, and balance of the funds. It references regulatory approvals, specific financial figures, and compliance with securities regulations. The document is titled as a "专项报告" (special report) on the annual storage and use of raised funds, which aligns with a capital/financing update rather than a full annual report or earnings release. It is not a brief announcement or a certification letter, but a substantive report on fundraising and fund usage. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 4289 characters, which is substantive enough for a report rather than a mere announcement.
2024-03-29 Chinese
2023年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as "2023 年年度报告摘要" which translates to "2023 Annual Report Summary". It contains detailed financial data, business overview, accounting policies, shareholder information, and management discussion. The document length is over 12,000 characters, indicating it is a substantive report rather than a brief announcement. It includes comprehensive financial figures for the year 2023, business operations, and strategic outlook, which are typical contents of an Annual Report. There is no indication that this is merely an announcement or a certification. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2024-03-29 Chinese
关于续聘2024年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the reappointment of the audit firm (天健会计师事务所) for the 2024 fiscal year. It details the audit firm's qualifications, past performance, independence, and the approval process by the board and audit committee. It does not contain actual financial statements or audit results but rather the decision and procedural information about continuing the audit engagement. The document length is 3351 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information (AR) type, as it relates specifically to audit firm appointment and audit-related information, but is not a full annual report or audit report itself. However, given the short length and nature as an announcement of audit firm reappointment, it aligns more closely with Audit Report / Information (AR) rather than a full Annual Report (10-K) or Regulatory Filing (RNS). FY 2023
2024-03-29 Chinese
大博医疗科技股份有限公司2024 年第一次独立董事专门会议决议
Board/Management Information Classification · 95% confidence The document is a resolution from the independent directors' special meeting of a company, detailing approvals on various governance and financial matters such as related party transactions, use of raised funds, external guarantees, appointment of audit firm, profit distribution plan, cash management, foreign exchange derivatives trading, internal control self-assessment, and a three-year shareholder dividend plan. It is dated March 27, 2024, and references compliance with relevant laws and regulations. The content is focused on board-level decisions and governance oversight rather than full financial statements or audit reports. The document length is about 2935 characters, which is relatively short and more consistent with meeting resolutions or board/management announcements rather than full reports. Therefore, this document fits best under Board/Management Information (MANG) as it announces board-level decisions and approvals from a special meeting of independent directors.
2024-03-29 Chinese
2023年度独立董事述职报告（王艳艳）
Board/Management Information Classification · 95% confidence The document is titled as the "2023年度独立董事述职报告" which translates to "2023 Annual Independent Director's Work Report." It details the independent director's activities, attendance at board and shareholder meetings, opinions on various company matters including audit, internal controls, related party transactions, and governance issues during the 2023 fiscal year. The content focuses on the independent director's duties, opinions, and oversight rather than presenting full financial statements or audit results. It is a report on board/management activities and governance oversight rather than a full annual report or audit report. Therefore, the document fits best under Board/Management Information (MANG) as it reports on board-level activities and management oversight by an independent director.
2024-03-29 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.